Tuesday, July 5, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Climate change might fuel future zoonotic events, pandemics

by Medical Finance
in Coronavirus
Study: Climate change increases cross-species viral transmission risk. Image Credit: the8monkey / Shutterstock
9
SHARES
100
VIEWS
Share on FacebookShare on Twitter

Coronavirus disease 2019 (COVID-19) is a zoonotic disease that spread from animals to humans. A great deal of media attention was paid when the pandemic was officially declared early in 2020, pointing to the theory that the disease had jumped from bats into humans at the Wuhan wet market, where wild animals are kept. Regardless of how well-supported this exact theory is, it has long been known that more zoonotic diseases are more likely to occur where animals are close to other animals and humans that they wouldn’t normally encounter. Researchers from Georgetown University have published research in the journal Nature, stimulating future zoonotic hotspots and projecting how climate change could affect these events.

Study: Climate change increases cross-species viral transmission risk. Image Credit: the8monkey / ShutterstockStudy: Climate change increases cross-species viral transmission risk. Image Credit: the8monkey / Shutterstock

The Study

Some species will likely try to migrate to new habitats as their climate changes. Most mammals’ ranges will overlap with at least one unfamiliar creature if species range changes keep pace with climate change in the near future. Even with the best possible outlooks on future emissions, this is no longer possible to change. This would represent a doubling of potential species contract, occurring everywhere across the world – but primarily in tropical Africa and Southeast Asia. Species will aggregate in most novel combinations when mountains act as physical barriers, preventing them from traveling further. Other hotspots will likely include the Amazon and central African basin, Botswana and parts of the Indian subcontinent. The predicted outcome of the increase in first encounters is a minimum of ~15,000 cross-species transmission events of at least one novel virus.

Novel viral sharing is likely to be limited at least in part by species’ intrinsic dispersal capacity. In their simulations, the researchers limited the dispersal potential of flightless species by taking into account body size, trophic rank and generation time. Generally, dispersal limits caused significant reductions in range expansions for all species. This model showed carnivores accounting for a slightly higher number of first encounters, and rodents marginally lower. Bats caused a disproportionately higher level of viral sharing, as the ability to fly allows them substantially higher dispersal capacity. Research has already shown that their distributions are rapidly changing, and bats account for nearly 90% of first encounters in all the examined scenarios.

A subnetwork of 13 possible hosts of the Zaire ebola virus was constructed, and potential first encounters were projected to illustrate the threat to human health. These 13 species would encounter between ~3,700 and ~2,500 new mammals, leading to at least one hundred new viral sharing events. As well as exposing a broader range of new species to the deadly virus, this could also increase the zoonotic niche of the ebolavirus across a much wider range of Africa, possibly increasing future outbreaks.

Ebola virus illustration. Image Credit: jaddingt / ShutterstockEbola virus illustration. Image Credit: jaddingt / Shutterstock

Unfortunately, even the most optimistic projections for a reduction in greenhouse gas emissions are unlikely to reduce the risk of climate-driven viral sharing. If global warming is slower, species are more likely to survive the range shifts and even more first encounters will occur. The authors highlight that this finding is limited to zoonotic events, and other climate-driven disasters could still be affected by changes in greenhouse gas emissions.

The timing of climate change was analyzed by reproducing the simulations with a new climate product that allowed a baseline to be set in the past, between 1980 and 2010, and then exploring the impact in three future time zones stretching between 2011 and 2100. The vast majority of the first encounters occurred in the first third of the century, but steady and sizable increases did continue until 2100. Unfortunately, this could indicate that the vast majority of climate-related zoonotic events could already have occurred – but only if the species’ habitat has shifted as quickly as the habitat suitability has.

Conclusions

Despite the authors’ acknowledgment that many and different ecological changes will complicate their predictions further, they nevertheless establish a strong correlation between climate change and cross-species viral transmission. In the future, this work can be better scaled to reflect individual areas and species more accurately, but this provides the first template for how viral emergence hotspots in wildlife can be predicted prior to introducing these viruses into human populations; potentially preventing future pandemics.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study:COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments. Image Credit: eamesBot/Shutterstock

Exploring biomedical literature and clinical trial records to identify new drug combinations for COVID-19 treatment

by Medical Finance
July 5, 2022
0

In a study published in the latest issue of the journal Pharmaceutics, researchers extensively searched publicly available severe acute respiratory...

Study: Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Image Credit: Sylfida/Shutterstock

Current progress in SARS-CoV-2 vaccine candidates

by Medical Finance
July 5, 2022
0

In a recent study posted to the journal Molecular Biology Reports, researchers illustrated the current progress and obstacles in the...

Study: Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening. Image Credit: Zerbor/Shutterstock

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

by Medical Finance
July 5, 2022
0

In a recent study posted to the bioRxiv* preprint server, researchers discovered compounds able to inhibit severe acute respiratory syndrome coronavirus...

Study: Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood. Image Credit: Yuganov Konstantin/Shutterstock

Study explores differentially expressed immune genes for COVID-19 patient stratification

by Medical Finance
July 5, 2022
0

In a recent pre-proof study posted to the journal Molecular Immunology, researchers determined the transcriptional signatures associated with the severity of...

Study: Racial/Ethnic Disparities in the Observed COVID-19 Case Fatality Rate Among the U.S. Population. Image Credit: emojoez/Shutterstock

Differences in observed COVID-19 case fatality rates between different racial groups in the US

by Medical Finance
July 5, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers assessed the disparities in coronavirus disease 2019 (COVID-19) case...

Image Credit: Knowledge and experience of physicians during the COVID-19 Pandemic: A global cross-sectional study. Image Credit: PopTika/Shutterstock

Physicians’ knowledge, attitudes, and preventative practices regarding the COVID-19 pandemic

by Medical Finance
July 5, 2022
0

In a recent study posted to Research Square*, researchers conducted a global survey to assess the knowledge, attitudes, and practices...

Next Post
Study: Reduced replication efficacy of SARS-CoV-2 Omicron variant in “mini-gut” organoids. Image Credit: Explode/Shutterstock

Infectivity of SARS-CoV-2 Omicron variant in the intestinal tract

Study: Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity. Image Credit: Naeblys/Shutterstock

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • bacteria Sebastian Kaulitzki 46826fb7971649bfaca04a9b4cef3309 620x480
    New ‘Labskin Microbiome Friendly+ Seal of Approval’ unveiled
  • Study: Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States — FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021). Image Credit: Gorodenkoff/Shutterstock
    COVID-19-related hospitalizations in children below 18 years with influenza-associated hospitalizations
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply